Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations

BMC Public Health

Volumn 17, Issue 1, 2017, Pages 1-8

  Delva, Fleur ^a,b,c   Margery, Jacques ^d,e,f   Laurent, François ^a,g,h   Petitprez, Karine ⁱ   Pairon, Jean Claude ^j,k,l  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSTITUT BERGONIÉ   (France)

^d PERCY MILITARY HOSPITAL   (France)

^e French Military Health Service Academy   (France)

^f Groupe d Oncologie de Langue Française GOLF   (France)

^g HAUT LÉVÊQUE HOSPITAL   (France)

^h Societe Francaise de Radiologie   (France)

ⁱ Ancien Délégué Général de la Fédération de l'Hospitalisation Privée   (France)

^j UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^k CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^l CCF   (France)

more..

Author keywords

Cancer screening; Lung neoplasms; Recommendations

Indexed keywords

CARCINOGEN;

ADVERSE EFFECTS; AGED; CHEMICALLY INDUCED; EARLY CANCER DIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; FRANCE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PREVENTION AND CONTROL; RISK FACTOR; SMOKING;

AGED; CARCINOGENS; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK FACTORS; SMOKING;

EID: 85012249334     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-017-4114-1     Document Type: Article

References (39)

1. International Agency for Research on Cancer. GLOBOCAN 2012. Cancer Incidence and Mortality Worldwide in 2012 Lyon, France. 2012. Available from: http://globocan.iarc.fr/Default.aspx. Accessed Sept 2014.
2. Imbernon E. Estimation du nombre de cas de certains cancers attribuables à des facteurs professionnels en France. France: Institut de Veille Sanitaire; 2002.
3. Nurminen M, Karjalainen A. Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scand J Work Environ Health. 2001;27(3):161-213.
4. Ameille J, Monnet I, Pairon J. Cancer bronchopulmonaire. In: Pairon JC, Brochard P, Le Bourgeois JP, Ruffié P, editors. Les cancers professionnels Tome, vol. 1. 2000. p. 371-401.
5. Ng G, Christiani D. Lung cancer. In: Hendrick DJ, Burge PS, Beckett WS, Churg A, editors. Occupational disorders of the lung Recognition, management and prevention. WB Saunders, Elsevier; 2002. p. 305-26.
6. Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med. 1996;29(5):474-90.
7. Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):694-705.
8. Consensus development conference for the elaboration of a clinical medical surveillance strategy for people exposed to asbestos. Paris, France, 15 January 1999. Rev Mal Respir. 1999;16(6 Pt 2):1187-362.
9. Haute Autorité de Santé. Post-professional follow-up after asbestos exposure. Rev Mal Respir. 2010;27(7):e17-33.
10. Mastrangelo G, Marangi G, Ballarin MN, Bellini E, De Marzo N, Eder M, et al. Post-occupational health surveillance of asbestos workers. La Medicina del lavoro. 2013;104(5):351-8.
11. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
12. American Lung Association. Providing Guidance on Lung Cancer Screening To Patients and Physicians. Chicago: American Lung Association; 2012. [Available from: http://www.lung.org/assets/documents/lung-cancer/lung-cancer-screening-report.pdf].
13. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-29.
14. Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, et al. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d’Oncologie de langue francaise (GOLF). Ann Oncol. 2013;24(3):586-97.
15. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e78S-92.
16. Frauenfelder T, Puhan MA, Lazor R, von Garnier C, Bremerich J, Niemann T, et al. Early detection of lung cancer: a statement from an expert panel of the Swiss university hospitals on lung cancer screening. Respiration; Int Rev Thorac Dis. 2014;87(3):254-64.
17. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33-8.
18. Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, et al. ESR/ERS white paper on lung cancer screening. Euro Respir J. 2015;46(1):28-39.
19. Roberts H, Walker-Dilks C, Sivjee K, Ung Y, Yasufuku K, Hey A, et al. Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol. 2013;8(10):1232-7.
20. Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8):1462-74.
21. Wender R, Fontham ET, Barrera Jr E, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107-17.
22. Haute Autorité de Santé. Méthodes d’élaboration des recommandations de bonne pratique. 2014. Available from: http://www.has-sante.fr/portail/jcms/c_418716/fr/methodes-d-elaboration-des-recommandations-de-bonne-pratique.
23. Guide méthodologique. Elaboration de recommandations de bonne pratique. France: Haute Autorité de Santé; 2010. Availbale on http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/11igm02-consultation-publique-guide-methodologique-v2-2012-10-18-14-16-44-998.pdf.
24. Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, et al. Long-term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med. 2015;191(10):1166-75.
25. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21(3):308-15.
26. Wille MM, Dirksen A, Ashraf H, Saghir Z, Bach KS, Brodersen J, et al. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Am J Respir Crit Care Med. 2016;193(5):542-51.
27. Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess (Winchester, England). 2016;20(40):1-146.
28. Ru Zhao Y, Xie X, de Koning HJ, Mali WP, Vliegenthart R, Oudkerk M. NELSON lung cancer screening study. Cancer Imaging. 2011;11 Spec No A:S79-84.
29. Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J cancer J Int du Cancer. 2001;91(6):876-87.
30. Société Française de Médecine du Travail. Paris FRA, Société de Pneumologie de Langue Française FRA, Société d’Imagerie Thoracique FRA, Ministère de l’Emploi et de la Solidarité. Paris FRAc. Conférence de consensus : Elaboration d’une stratégie de surveillance médicale clinique des personnes exposées à l’amiante. Energies Sante. 1999;10(2-93):218-30.
31. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(5):311-20.
32. Fitzgerald NR, Flanagan WM, Evans WK, Miller AB. Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals. Scand J Work Environ Health. 2015;41(4):407-12.
33. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369(3):245-54.
34. McKee BJ, Hashim JA, French RJ, McKee AB, Hesketh PJ, Lamb CR, et al. Experience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer J Am Coll Radiol. 2015;12(2):192-7.
35. Tammemagi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al. Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts. PLoS Med. 2014;11(12):e1001764.
36. Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for Lung Cancer: Systematic Review to Update the US Preventive Services Task Force Recommendation. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Rockville (MD). 2013.
37. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer (Amsterdam, Netherlands). 2006;54(2):177-84.
38. Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, et al. Cost-Effectiveness of CT Screening in the National Lung Screening Trial. N Engl J Med. 2014;371(19):1793-802.
39. Coureau G, Salmi LR, Etard C, Sancho-Garnier H, Sauvaget C, Mathoulin-Pelissier S. Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials. Eur J Cancer (Oxford, England : 1990). 2016;61:146-56.